Dear readers, we are following the monkeypox virus development closely and it seems the transmission of the virus may be different from previous versions.

We are hoping we are dead wrong when it comes to a potential new pandemic event but until the DNA of this virus has been completely analyzed and mapped we will continue to execute extreme cautions in the markets. We have sold our Emergent Biosolutions positions and reallocated the funds to Bavarian Nordic. Our target price and potential exit level in Bavarian Nordic is 300 DKK.


Stay updated on our twitter account for the latest update as the events of the Monkeypox virus is escalating quickly.

We also advise caution for the upcoming Fed meeting in early june which may strike a big blow to growth stocks if the consumer price index numbers coming out in June show no sign of slowing down. The ESGFIRE portfolio remains 60 % cash and with a large position in Bavarian Nordic as hedge.


Investing in stocks is combined with certain risks and it is possible to lose your entire investment. Our posts are made for Educational purposes only and are not to be interpreted as tips , financial advice or recommendations of any kind to either buy or sell any stocks.